date:Oct 31, 2012
growth with strategic bolt-on acquisitions. This transaction represents an excellent strategic fit for our HealthCare business, said Dr Marijn Dekkers, Bayer AGs chief executive.
The Schiff business significantly enhances our presence and position in the United States, which accounts for more over-the-counter and nutritional products sales than any other country in the world.
We are focused on building premium brands and leading innovation. We believe Bayer is well positioned to take our lead